Overview

This conference aims to educate practitioners and update their knowledge of advances in diagnosing and managing Breast, Genitourinary, and Gynecological Cancers.

Learning Objectives

After participating in these activities, learners will be better able to:

• Analyze the current and future applications of newly approved targeted therapies across breast cancer sub-types
• Recognize and manage the side effects of innovative, practice-changing therapies and incorporate them into community practice
• Understand new diagnostics and treatments in the management of Renal, Urothelial, and Prostate cancers

Target Audience

The target audience for this conference is medical oncologists, hematologists, pathologists, oncology nurses, fellows, residents, advanced practice providers, family practitioners, primary care practitioners, allied health professionals, and other providers interested in the care of patients with cancer.

Accreditation

Global Education Group designates these live activities for a maximum of 3.0 AMA PRA Category 1 Credits™ each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.